In a new study, a mass vaccination campaign for a meningitis outbreak in New Zealand has offered the unintended benefit of helping reduce gonorrhea incidence. Should we expect a gonorrhea vaccine soon amid the threat of antibiotic resistance?
In a new study, a mass vaccination campaign for a meningitis outbreak in New Zealand has offered the unintended benefit of helping reduce gonorrhea incidence. Should we expect a gonorrhea vaccine soon amid the threat of antibiotic resistance?